121 related articles for article (PubMed ID: 8075357)
1. Metabolic studies on haloperidol and its tetrahydropyridine analog in C57BL/6 mice.
Van der Schyf CJ; Castagnoli K; Usuki E; Fouda HG; Rimoldi JM; Castagnoli N
Chem Res Toxicol; 1994; 7(3):281-5. PubMed ID: 8075357
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon.
Avent KM; Usuki E; Eyles DW; Keeve R; Van der Schyf CJ; Castagnoli N; Pond SM
Life Sci; 1996; 59(17):1473-82. PubMed ID: 8890926
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.
Castagnoli N; Castagnoli KP; Van der Schyf CJ; Usuki E; Igarashi K; Steyn SJ; Riker RR
Pol J Pharmacol; 1999; 51(1):31-8. PubMed ID: 10389142
[TBL] [Abstract][Full Text] [Related]
4. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
Usuki E; Pearce R; Parkinson A; Castagnol N
Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia.
Eyles DW; McLennan HR; Jones A; McGrath JJ; Stedman TJ; Pond SM
Clin Pharmacol Ther; 1994 Nov; 56(5):512-20. PubMed ID: 7955815
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.
Brand L; Oliver DW; van der Schyf CJ; Pond SM; Castagnoli N
Life Sci; 1996; 59(10):815-20. PubMed ID: 8761315
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study.
Van der Schyf CJ; Dormehl IC; Oliver DW; Hugo N; Keeve R; Müller-Gärtner HW; Pond SM; Castagnoli N
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):251-8. PubMed ID: 9037540
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.
Igarashi K; Kasuya F; Fukui M; Usuki E; Castagnoli N
Life Sci; 1995 Nov; 57(26):2439-46. PubMed ID: 8847965
[TBL] [Abstract][Full Text] [Related]
10. Metabolic studies on haloperidol and its tetrahydropyridinyl dehydration product (HPTP) in C57BL/6 mouse brain preparations.
Usuki E; Bloomquist JR; Freeborn E; Casagnoli K; Van Der Schyf CJ; Castagnoli N
Neurotox Res; 2002 Feb; 4(1):51-8. PubMed ID: 12826493
[TBL] [Abstract][Full Text] [Related]
11. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
[TBL] [Abstract][Full Text] [Related]
12. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.
Wright AM; Bempong J; Kirby ML; Barlow RL; Bloomquist JR
Brain Res; 1998 Mar; 788(1-2):215-22. PubMed ID: 9555021
[TBL] [Abstract][Full Text] [Related]
13. Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats.
Subramanyam B; Rollema H; Woolf T; Castagnoli N
Biochem Biophys Res Commun; 1990 Jan; 166(1):238-44. PubMed ID: 2302206
[TBL] [Abstract][Full Text] [Related]
14. Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
Kalgutkar AS; Nguyen HT
Drug Metab Dispos; 2004 Sep; 32(9):943-52. PubMed ID: 15319335
[TBL] [Abstract][Full Text] [Related]
15. Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite.
Fang J; Gorrod JW
Toxicol Lett; 1991 Dec; 59(1-3):117-23. PubMed ID: 1755019
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
[TBL] [Abstract][Full Text] [Related]
17. Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+.
Kawashima H; Iida Y; Kitamura Y; Kiyono Y; Magata Y; Saji H
Jpn J Pharmacol; 2002 Aug; 89(4):426-8. PubMed ID: 12233823
[TBL] [Abstract][Full Text] [Related]
18. Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem.
Eyles DW; Avent KM; Stedman TJ; Pond SM
Life Sci; 1997; 60(8):529-34. PubMed ID: 9042387
[TBL] [Abstract][Full Text] [Related]
19. Influence of lipophilicity on the interactions of N-alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and their positively charged N-alkyl-4-phenylpyridinium metabolites with cytochrome P450 2D6.
Kalgutkar AS; Zhou S; Fahmi OA; Taylor TJ
Drug Metab Dispos; 2003 May; 31(5):596-605. PubMed ID: 12695348
[TBL] [Abstract][Full Text] [Related]
20. Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite.
Subramanyam B; Woolf T; Castagnoli N
Chem Res Toxicol; 1991; 4(1):123-8. PubMed ID: 1912294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
